Manuka Honey and Cancer
Based on the highest quality guideline evidence, manuka honey should NOT be used as a treatment or adjunctive therapy for cancer. The 2022 Society for Integrative Oncology-ASCO guideline explicitly states there is inconclusive evidence to recommend for or against honey for oral mucositis in cancer patients, and the largest, most rigorous trial showed manuka honey was not superior to standard supportive care 1.
Key Evidence from Clinical Guidelines
For Cancer Treatment-Related Complications
The most definitive evidence comes from the NRG Oncology clinical trial network (the largest and most rigorously designed study), which tested liquid manuka honey and manuka honey lozenges versus standard supportive care in preventing radiation esophagitis in lung cancer patients. Neither honey preparation was superior to supportive care 1. This trial is particularly important because:
- It was conducted within a major clinical trials network
- It had the most rigorous design among 19 trials testing honey
- The negative results occurred despite testing two different manuka honey formulations
The guideline notes that the honey in this trial was irradiated, which may have inhibited beneficial bacterial effects, but this caveat does not change the recommendation given the overall inconsistent evidence across all 19 trials 1.
For Diabetic Foot Ulcers
The 2024 IWGDF guidelines provide a strong recommendation against using honey (including bee-related products) for wound healing in diabetes-related foot ulcers, with low certainty of evidence 2. While this addresses a different condition, it demonstrates that even in wound healing contexts, honey lacks sufficient evidence.
For GERD (Not Cancer)
One study showed potential benefit for GERD 3, but this is irrelevant to cancer treatment and should not influence cancer-related decisions.
Preclinical Research Does Not Support Clinical Use
While recent laboratory studies (2024) show manuka honey may have anti-cancer properties in cell cultures and animal models 4, 5, 6, 7, 8, including:
- Inhibition of breast cancer cell proliferation 5
- Anti-metastatic effects on colon cancer stem cells 6
- Chemosensitization of colon cancer cells to 5-Fluorouracil 7
- IFNγ-dependent tumor growth resistance in mice 4
These laboratory findings do not translate to clinical recommendations. The gap between preclinical promise and clinical efficacy is enormous in oncology, and the actual human trial data contradicts any benefit.
Clinical Algorithm
For patients asking about manuka honey in cancer:
If asking about direct anti-cancer effects: Explain there is no clinical evidence supporting manuka honey as cancer treatment. The preclinical studies are preliminary and do not justify clinical use.
If asking about oral mucositis prevention/treatment during radiation/chemotherapy:
- Do not recommend manuka honey
- The largest rigorous trial showed no benefit over standard care
- Standard care (viscous lidocaine, antacids, opioids as needed) remains the evidence-based approach 9
If patient insists on trying it anyway:
- Emphasize it should never replace standard cancer treatment
- Note it was not harmful in trials, but also not beneficial
- Warn that irradiated honey (common in commercial products) may have even less potential benefit
Important Caveats
- Heterogeneity problem: No two trials used the same honey preparation, dose, mode, or timing of delivery, making it impossible to identify an effective protocol even if benefit existed 1
- Quality issues: Most trials had unclear endpoints and inadequate power to detect differences 1
- Irradiation concern: Commercial honey products are often irradiated for safety, which may eliminate any theoretical beneficial bacterial effects 1
Bottom Line
The evidence hierarchy clearly prioritizes the 2022 ASCO-SIO guideline conclusion over preclinical research. Manuka honey has no established role in cancer treatment or management of cancer treatment complications. Patients should focus on evidence-based standard therapies rather than unproven natural products, regardless of promising laboratory findings.